Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments
Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments ACCESSWIRE Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 f...
United States Brian John Indications In Clinical Development Skin Cancer Foundation Company Investigational New Drug Jupiter Wellness Inc
Source: phoenixherald.com